medigraphic.com
ISSN 2007-6509 (Impreso)
Órgano oficial de la Asociación Mexicana de Medicina Transfusional A.C.

2014, Número 2

<< Anterior Siguiente >>

Rev Mex Med Transfus 2014; 7 (2)


Empleo de plasma rico en factores de crecimiento, derivado de plaquetas y aspirado de medula ósea para el tratamiento de una fractura con falla de consolidación

Benítez AG, Vázquez CR

Idioma: Español
Referencias bibliográficas: 23
Paginas: 12-13
Archivo PDF: 615.78 Kb.


FRAGMENTO

Introducción

El empleo de factores de crecimiento autólogos, así como el de células autólogas, para el tratamiento de lesiones músculo-esqueléticas y de tejidos blandos es una opción terapéutica que en los últimos años se ha posicionado en el campo de la ortopedia y cirugía plástica con resultados alentadores, representando una opción terapéutica accesible y segura para el paciente. Asimismo, es un área de oportunidad de desarrollo para la medicina transfusional, ya que son los bancos de sangre donde se pueden desarrollar productos de alto valor terapéutico, como los facto- res de crecimiento derivados de plaquetas y colas hemostáticas, entre otros.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Rivera MP. Empleo de plasma rico en plaquetas (terapia ce- lular) e injertos en malla para el manejo de úlceras crónicas. Estudio comparativo. Cir Plast. 2012; 22 (1): 17-21

  2. Pereira RC, Scaranari M, Benelli R, Strada P, Reis RL, et al. Dual Effect of Platelet Lysate on Human Articular Cartilage: A Maintenance of Chondrogenic Potential and a Transient Pro- inflammatory Activity Followed by an Inflammation Resolu- tion. Tissue Engineering Part A. 2013; 19 (11-12): 1476-1488. doi:10.1089/ten.tea. 2012.0225.

  3. Ruggiua A, Ulivia V, Sanguineti F, Cancedda R, Descalzi F. The effect of Platelet Lysate on osteoblast proliferation asso- ciated with a transient increase of the inflammatory response in bone regeneration. Biomaterials 2013; (34) 37: 9318–9330

  4. El Backly RM, Zaky SH, Muraglia A, Tonachini L, Brun F et al. A Platelet-Rich Plasma-Based Membrane as a Periosteal Subs- titute with Enhanced Osteogenic and Angiogenic Properties: A New Concept for Bone Repair. Tissue Engineering Part A. 2013; 19 (1-2): 152-165. doi:10.1089/ten.tea. 2012.0357.

  5. Kang YH, Jeon SH, Park JY, Chung JH, Choung YH, et al. Platelet-Rich Fibrin is a Bioscaffold and Reservoir of Growth Factors for Tissue Regeneration. Tissue Engineering Part A. 2011: 349-359.

  6. Lee DH, Ryu KJ, Kim JW, Kang KC, Choi YR. Bone Marrow As- pirate Concentrate and Platelet-rich Plasma Enhanced Bone Healing in Distraction Osteogenesis of the Tibia. Clin Orthop Relat Res. 2014

  7. Kollitz KM, Parsons EM, Weaver MS, Huang JI.Platelet- rich plasma for zone II flexor tendon repair.Hand. 2014; 9 (2): 217-24.

  8. Sommeling, C. E., Heyneman, A., Hoeksema, H., Verbelen, J., Stillaert, F. B., & Monstrey, S. The use of platelet-rich plasma in plastic surgery: a systematic review. Journal of Plastic, Re- constructive & Aesthetic Surgery, 2013; 66 (3), 301-311.

  9. Gentile, P., Di Pasquali, C., Bocchini, I., Floris, M., Eleonora, T., Fiaschetti, V., y Cervelli, V. Breast reconstruction with autolo- gous fat graft mixed with platelet-rich plasma. Surgical Innova- tion. 2013; 20 (4), 370-376.

  10. Doucet C, Ernou I, Zhang Y et al. Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for ani- mal serum in cell-based therapy applications. J Cell Physiol. 2005;205:228 –236

  11. Kocaoemer A., Kern S., Klüter H. and Bieback K. Human AB Serum and Thrombin-Activated Platelet-Rich Plasma Are Suitable Alternatives to Fetal Calf Serum for the Expansion of Mesenchymal Stem Cells from Adipose Tissue. STEM CELLS.2007; 25: 1270–1278

  12. Malhotra A., Pelletier M., Oliver, R., Christou C., Walsh, W. R. Platelet-Rich Plasma and Bone Defect Healing. Tissue Engi- neering Part A 2014. doi:10.1089/ten.tea. 2013.0737

  13. Lee DH, Ryu KJ, Kim JW, Kang KC, Choi YR. Bone Marrow As- pirate Concentrate and Platelet-rich Plasma Enhanced Bone Healing in Distraction Osteogenesis of the Tibia. Clin Orthop Relat Res. 2014; 6.

  14. Xie X., Zhang Ch., Tuan RS. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Research & Therapy 2014, 16:204

  15. Makhdom AM, Hamdy RC.The Role of Growth Factors on Ac- celeration of Bone Regeneration During Distraction Osteoge- nesis. Tissue Engineering Part B: Reviews. 2013: 442-453

  16. Braun HJ, Kim HJ, Chu CR, Dragoo JL.The Effect of Platelet- Rich Plasma Formulations and Blood Products on Human Sy- noviocytes: Implications for Intra-articular Injury and Therapy. Am J Sports Med. 2014; 42 (5): 1204-10

  17. Dietrich M, Heselhaus J, Wozniak J, Weinandy S, Mela P, et al. Fibrin-Based Tissue Engineering: Comparison of Different Me- thods of Autologous Fibrinogen Isolation Tissue Engineering Part C: Methods. 2013, 19 (3): 216-226.

  18. Fisher MB, Mauck RL. Tissue Engineering and Regenerative Medicine: Recent Innovations and the Transition to Translation Tissue Engineering Part B: Reviews. 2013, 19 (1): 1-13

  19. Burnouf T. Platelet gels. ISBT Science Series. 2013, 8: 131–136.

  20. Rodriguez IA, Sell SA, McCool JM, Saxena G, Spence AJ, Bowlin GL. A Preliminary Evaluation of Lyophilized Gelatin Sponges, Enhanced with Platelet-Rich Plasma, Hydroxyapa- tite and Chitin Whiskers for Bone Regeneration. Cells. 2013; 2 (2): 244-265.

  21. Zhou B, Ren J, Ding C, Wu Y, Chen J, Wang G, Gu G, Li J. Protection of colonic anastomosis with platelet-rich plasma gel in the open abdomen. Injury. 2014;45 (5): 864-8

  22. Marck RE, Middelkoop E, Breederveld RS. Considerations on the use of platelet-rich plasma, specifically for burn treatment. J Burn Care Res. 2014; 35 (3): 219-27.

  23. Burnouf T., Goubran H.A., Chen T.M., Ou K.L., El-Ekiaby M., Radosevic M. Blood-derived biomaterials and platelet growth factors in regenerative medicine. Blood Rev. 2013; 27 (2): 77-89.




2020     |     www.medigraphic.com